Metabolic activation of mitomycin C by NADPH-ferredoxin reductase in vitro

Life Sciences

Volumn 68, Issue 14, 2001, Pages 1677-1685

  Jiang, Hou Bo ^a   Ichikawa, Minoru ^b   Furukawa, Aizo ^a   Tomita, Shuhei ^a   Ohnishi, Taira ^a   Ichikawa, Yoshiyuki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

DNA damage; Ferredoxin; Mitomycin C; NADPH ferredoxin reductase

Indexed keywords

4 (4 NITROBENZYL)PYRIDINE; CATALASE; CYTOCHROME P450; FERREDOXIN; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; FLAVINE ADENINE NUCLEOTIDE; MITOMYCIN C; PLASMID DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE;

ALKYLATION; ARTICLE; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG ACTIVATION; DRUG EFFECT; ENZYME ACTIVITY; HYPOXIA; METABOLIC ACTIVATION; NONHUMAN; REDUCTION; RESPIRATORY CHAIN; STEROID HYDROXYLATION;

ALKYLATION; ANIMALS; ANOXIA; ANTIBIOTICS, ANTINEOPLASTIC; BIOTRANSFORMATION; CATTLE; DNA DAMAGE; ESCHERICHIA COLI; FERREDOXIN-NADP REDUCTASE; MITOMYCIN; OXIDATION-REDUCTION;

MAMMALIA;

EID: 0035936715     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)00959-6     Document Type: Article

References (29)

1. Steroidogenic electron transport in adrenal cortex mitochondria
2. Studies on adrenal steroid hydroxylases: Complex formation of the hydroxylase components
3. Adrenodoxin reductase. Adrenodoxin complex
4. Crystalline reduced nicotinamide adenine dinucleotide phosphate-adrenodoxin reductase from pig adrenocortical mitochondria: Essential histidyl and cysteinyl residues of the NADPH-binding site and environment of the adrenodoxin-binding site
5. cDNA cloning of mouse ferredoxin reductase from kidney
6. Transcriptional regulation of the CYP1A1 and ferredoxin genes
7. Molecular cloning of sheep and goat ferredoxin reductase messenger ribonucleic acids, and identification of an alternatively spliced form of sheep ferredoxin reductase
8. Enzymology of mitomycin C metabolic activation in tumour tissue
9. Mitomycin C: A prototype bioreductive agent
10. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase
11. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C
12. Reaction of DNA with chemically or enzymatically activated mitomycin C: Isolation and structure of the major covalent adduct
13. 5 reductase
14. Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors
15. Kinetics and mechanism of mitomycin C bioactivation by xanthine dehydrogenase under aerobic and anaerobic conditions
16. Matabolism of mitomycin C by DT-diaphorase: Role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells
17. Reductive activation of mitomycin C by neuronal nitric oxide synthase
18. Relevance of DT-diaphorase activity to mitomycin C efficacy on human cancer cells differences in vitro and in vivo systems
19. Enzymology of bioreductive drug activation
20. Non-enzymatic and enzymatic activation of mitomycin C: Identification of a unique cytosolic activity
21. Enzymology of mitomycin C metabolic activation in tumor tissue: Characterization of a novel mitochondrial reductase
22. Heterogeneity of adrenocortical ferredoxin
23. Neuronal nitric oxide synthase catalyzes the reduction of 7-ethoxyresorufin
24. Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: A direct role for NADPH:cytochrome P450 oxidoreductase
25. A native cooperativity between NADPH and adrenodoxin on binding to NADPH:adrenodoxin reductase
26. + reductase with nonphysiological oxidants
27. Bioactivation as a model for drug design bioreductive alkylation
28. Mitomycin C-DNA adducts generated by DT-diaphorase. Revised mechanism of the enzymatic reductive activation of mitomycin C